Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intrastromal Presbyopia Correction by Means of a Femtosecond Laser

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01025050
Recruitment Status : Completed
First Posted : December 3, 2009
Last Update Posted : June 9, 2011
Sponsor:
Information provided by:
Technolas Perfect Vision GmbH

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
This clinical study is an open, prospective, multi-centre eye study consisting of three study arms to determine the safety and efficacy of intrastromal incisions for the correction of visual acuity on presbyopic eyes. The hypothesis of the study is that by means of intrastromal incisions, near visual acuity can be improved in presbyopic eyes in a safe and effective way.

Condition or disease Intervention/treatment Phase
Presbyopia Procedure: Intrastromal Correction of Presbyopia Phase 3

Detailed Description:

This clinical study is an open, prospective, multi-centre eye study consisting of three study arms to determine the safety and efficacy of intrastromal incisions for the correction of visual acuity on presbyopic eyes. The incisions are applied by means of the FEMTEC femtosecond laser system with the INTRACOR software module using patterns consisting of 6 concentric rings and 3 different inner ring diameters. A similar pattern with 5 concentric rings and only one fixed inner diameter is currently under clinical investigation.

The hypothesis of the study is that by means of intrastromal incisions, near visual acuity can be improved in presbyopic eyes in a safe and effective way.

The intrastromal incisions are performed by the femtosecond laser FEMTEC, which is CE certified for various therapeutic indications. The incision eliminates both an epithelial and an endothelial opening of the cornea whereby the minimally invasive character of this form of treatment is guaranteed. A detailed pre-operative examination will ensure that every interested and willing patient fulfils the inclusion criteria of this study. Post-operative examinations, which should document the success of the treatment, are to be carried out after 24 hours, 1 week, 1 month, 3 months and 6 months.

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 58 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Intrastromal Presbyopia Correction by Means of a Femtosecond Laser
Study Start Date : December 2009
Actual Primary Completion Date : May 2010
Actual Study Completion Date : December 2010
Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Group A
In this group the smallest ring diameter will be applied.
 Procedure: Intrastromal Correction of Presbyopia
On all patients an intrastromal pattern consisting of concentric rings will be applied.
Experimental: Group B
In this group the intermediate ring diameter will be applied.
 Procedure: Intrastromal Correction of Presbyopia
On all patients an intrastromal pattern consisting of concentric rings will be applied.
Experimental: Group C
In this group the biggest ring diameter will be applied.
 Procedure: Intrastromal Correction of Presbyopia
On all patients an intrastromal pattern consisting of concentric rings will be applied.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. The proportion of treated eyes who gained uncorrected near visual acuity of at least 2 lines. This proportion should be greater than 70%. [ Time Frame: 6 months follow up ]

Secondary Outcome Measures :
  1. The proportion of treated eyes that lose more than two lines of best corrected visual acuity (BSCVA). This proportion should be no greater than 5 %. [ Time Frame: 6 months follow up ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age: at least 18 years old
  • Patients must have read, understood and signed the Patient Information
  • Patients are willing and able to return for follow-up examinations
  • Stable distance refraction

  • Manifested Refraction (see Table 1 for more details) :

    • Cylinder: -0.5 D to 0 D
    • Sphere: 0.25 D to 1.25 D
    • Spherical equivalent: Minimum 0.25 D
  • Best corrected distance visual acuity of the eye to be treated at least 0.8
  • Subjects must have presbyopia as determined by an age-related need for optical aid (≥ +1.5 D) for reading with their best distance correction.

Exclusion Criteria:

  • Minimum cornea thickness < 500 µm
  • Ocular dominance (only non-dominant eyes should be included)
  • Uncorrected Near Visual Acuity of 0.5 or better
  • Difference between manifested and cycloplegic refraction of > 0.75 D in spherical equivalent
  • Median K values < 40 D or > 46 D
  • Topographical astigmatism > 5 D
  • Abnormal corneal topography
  • Patients with previous corneal operations on the eye to be treated (e.g. LASIK, PRK, X-Linking; this does not include cataract operations)
  • Scarring or opacity of the cornea
  • Transplanted cornea
  • Connective tissue weaknesses
  • Keratectasia and other diseases of the cornea
  • Patients with wound-healing disorders such as connective tissue disease, autoimmune illnesses, immunodeficiency illnesses, ocular herpes zoster or simplex, endocrine diseases, lupus, rheumatoid arthritis
  • Patients regularly taking medicines that could influence the result of the treatment
  • Glaucoma or a risk of glaucoma
  • Patients with concentration disorders, epilepsy, diabetes mellitus and other complicating diseases
  • Patients with disorders of the ocular muscle, such as nystagmus or strabismus
  • Sensitivities to the drugs used in this study
  • Continual wearing of contact lenses before the pre-examination and before the operation. Patients must refrain from wearing contact lenses for at least 14 days prior to these dates
  • Patients who are pregnant or are lactating
  • Patients who are participating in another ophthalmological clinical study
  • Best corrected distance visual acuity of the second, not to be treated eye is 0.5 or less.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01025050


Locations
Layout table for location information
Germany
University Eye Clinic Heidelberg
Heidelberg, Baden-Württemberg, Germany, 69120
FreeVis LASIK Center Mannheim GmbH
Mannheim, Baden-Württemberg, Germany, 68167
Augenklinik am Marienplatz AG & Co. KG
Munich, Bavaria, Germany, 80331
Eye-clinic for Refractive and Ophthalmo-Surgery, EJK Niederrhein
Duisburg, North Rhine-Westphalia, Germany, 47169
Sponsors and Collaborators
Technolas Perfect Vision GmbH
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: Priv.-Doz. Dr. med. Mike P. Holzer, University Ophthalmic Clinic, Heidelberg
ClinicalTrials.gov Identifier: NCT01025050    
Other Study ID Numbers: 0905
First Posted: December 3, 2009    Key Record Dates
Last Update Posted: June 9, 2011
Last Verified: June 2011
Keywords provided by Technolas Perfect Vision GmbH:
Presbyopia
Intrastromal
Femtosecond Laser
 minimal-invasive
INTRACOR
Enhance Near Visual Acuity
Additional relevant MeSH terms:
Layout table for MeSH terms
Presbyopia
Refractive Errors
Eye Diseases